SCHEMBL5347306

SCHEMBL5347306

Cc1cccc(S(=O)(=O)N2CCCN(c3c(Cl)cncc3Cl)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 4/20 0.51
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 6/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HTT P42858 4/20 0.46
POLB P06746 3/20 0.46
MAPT P10636 2/20 0.46
GAA P10253 1/20 0.46
PKM P14618 3/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5325655 0.88 ALDH1A1 (0.64) LMNATSHRALDH1A1MEN1KMT2A
SCHEMBL5323167 0.85 PKM (0.64) LMNAL3MBTL1USP2TSHRTDP1
SCHEMBL5349081 0.85 TSHR (0.55) LMNAL3MBTL1TSHRALDH1A1MEN1
SCHEMBL16707660 0.85 MEN1 (0.55) LMNAL3MBTL1TDP1ALDH1A1MEN1
SCHEMBL5455187 0.83 KDM4E (0.61) LMNAL3MBTL1HTTPOLBGAA
SCHEMBL3216015 0.83 ALDH1A1 (0.62) LMNATSHRTDP1ALDH1A1MEN1
SCHEMBL17029173 0.82 LMNA (0.50) LMNAALDH1A1MEN1KMT2AHTT
SCHEMBL5323174 0.81 MCOLN3 (0.60) LMNATSHRMEN1KMT2AHTT
SCHEMBL5352439 0.79 MCOLN3 (0.50) LMNAL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL5331427 0.79 CHRM4 (0.48) LMNAL3MBTL1TSHRTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO claimed
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO disclosed
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO disclosed